ERN1 and pancreatic neoplasm: Notably, ERN1 silencing reversed the chemo-sensitive phenotype of these two cell lines (Fig. 4f, 4g), providing a molecular link between the MIA2I141M variant and pancreatic cancer cell chemo-response.